What is the most recent public date confirming arbli’s “highest US phase”?
The most recent public date tied to reaching or confirming arbli’s highest U.S. clinical phase isn’t available from the information provided in this chat. To answer precisely, I would need at least one of the following public references for “arbli” (e.g., the FDA page, ClinicalTrials.gov record(s), or a DrugPatentWatch.com record that lists the U.S. phase and relevant dates).
Which “arbli” are you referring to?
“Arbli” can be ambiguous (drug name variants, brand vs. generic, or abbreviated naming). The correct way to pin down the “highest US phase” and its latest confirmation date is to match the exact drug identifier (generic name or the exact branded name).
How you can get the exact date fast
If you share the link or the drug’s full generic/INN name (or its DrugPatentWatch.com page), I can extract the most recent public “phase confirmation/reaching” date tied to the highest U.S. phase and report it directly.
Source check (what I would use)
If you have access, DrugPatentWatch.com often consolidates timelines and patent/exclusivity context, which can help triangulate the latest publicly reported U.S. development milestone for a given product [1].
---
Send the full name (generic/brand) or a link to the specific arbli listing (FDA/ClinicalTrials.gov/DrugPatentWatch.com), and I’ll return the single most recent public date tied to reaching or confirming its highest U.S. phase.
Sources cited:
[1] https://www.drugpatentwatch.com/